Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study

Part of paid clinical trials in Gainesville, Florida.

Sponsor
Bluejay Diagnostics, Inc.
Study ID
NCT06654895
Status
Recruiting
Apply to this trial

Conditions

  • Sepsis, Septic Shock

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.

Key Dates

Start date
Nov 12, 2024
Status verified
Dec 2025
Primary completion
Aug 30, 2026
Completion
Aug 30, 2026

Study Design

Enrollment
700 participants (estimated)

Primary Outcome Measure

28-day all-cause mortality [Time Frame: within 28 days after inclusion] participants will be followed up for 28 days [ Time Frame: Within 28 days after inclusion ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
University of Florida College of MedicineGainesvilleFlorida32610
Office of Research College of Medicine
[email protected]
352-273-5946
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Clinical Affairs
Wake Forest School of MedicineWinston-SalemNorth Carolina27157
Clinical Translation Science Institute
[email protected]
336-716-1195
Vanderbilt University Medical CenterNashvilleTennessee37232
VUMC Office of Research
[email protected]
615-322-5000
Intermountain HealthSalt Lake CityUtah84111
Clinical Affairs

Find similar trials in Gainesville, FL

By research site
University of Florida College of Medicine· Gainesville, FLBeth Israel Deaconess Medical Center· Boston, MAWake Forest School of Medicine· Winston-Salem, NCVanderbilt University Medical Center· Nashville, TNIntermountain Health· Salt Lake City, UT

Related Studies